A randomized controlled trial of pegylated interferon-alpha with tenofovir disoproxil fumarate for hepatitis B e antigen-negative chronic hepatitis B: A 48-week follow-up study

This publication has 25 references indexed in Scilit:

• Reduction of HBV replication prolongs the early immunological response to IFNα therapy
  Journal of Hepatology, 2014
• Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
  The Lancet, 2013
• Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide Analogues
  Gastroenterology, 2012
• Chronic Hepatitis B Infection
  Clinics in Liver Disease, 2012
• Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients
  Hepatology International, 2012
• A randomized controlled trial of pegylated interferon-α2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B
  Antiviral Therapy, 2009
• Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
  New England Journal of Medicine, 2008
• Sustained HBeAg and HBsAg Loss After Long-term Follow-up of HBeAg-Positive Patients Treated With Peginterferon α-2b
  Gastroenterology, 2008
• Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
  Hepatology International, 2008
• Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV‐coinfected patients: factors associated with response
  Journal of Viral Hepatitis, 2006